TC BioPharm (Holdings) plc (NASDAQ: TCBP)
$0.84
+0.0210 ( +2.56% ) 24.2K
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
Market Data
Open
$0.84
Previous close
$0.82
Volume
24.2K
Market cap
$4.19M
Day range
$0.80 - $0.85
52 week range
$0.72 - $19.60
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 4 | Jul 01, 2024 |
6-k | Quarterly Reports | 4 | Jul 01, 2024 |
8-k | 8K-related | 14 | Jun 28, 2024 |
def | Proxies and info statements | 4 | Jun 07, 2024 |
8-k | 8K-related | 14 | May 29, 2024 |
pre | Proxies and info statements | 2 | May 28, 2024 |
8-k | 8K-related | 14 | May 20, 2024 |
10-q | Quarterly Reports | 71 | May 15, 2024 |
8-k | 8K-related | 17 | May 08, 2024 |
8-k | 8K-related | 16 | May 06, 2024 |